Orion Corporation
We're a globally operating Nordic pharmaceutical company that's been building well-being for over a century. Founded in 1917, we develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Our extensive portfolio includes proprietary and generic medicines along with consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain, with our proprietary products used to treat cancer, neurological diseases and respiratory diseases, among others. We operate as a publicly traded company listed on Nasdaq Helsinki, with about 3,700 professionals worldwide dedicated to our mission. In 2024, our net sales reached EUR 1,542 million. We believe that health and well-being create the foundation for a good life, and we work every day to address unmet medical needs and strengthen healthcare systems by making high-quality medicines accessible and affordable.
We're a globally operating Nordic pharmaceutical company that's been building well-being for over a century. Founded in 1917, we develop, manufacture and market human and veterinary pharmaceuticals and active pharmaceutical ingredients. Our extensive portfolio includes proprietary and generic medicines along with consumer health products. The core therapy areas of our pharmaceutical R&D are oncology and pain, with our proprietary products used to treat cancer, neurological diseases and respiratory diseases, among others.
We operate as a publicly traded company listed on Nasdaq Helsinki, with about 3,700 professionals worldwide dedicated to our mission. In 2024, our net sales reached EUR 1,542 million. We believe that health and well-being create the foundation for a good life, and we work every day to address unmet medical needs and strengthen healthcare systems by making high-quality medicines accessible and affordable.